New combo therapy shows promise in tough pancreatic cancer

NCT ID NCT04257448

First seen Sep 30, 2025 · Last updated Jun 06, 2026 · Updated 32 times

Summary

This study tested a new treatment plan for people with advanced pancreatic cancer that has spread. It combined chemotherapy with drugs that change how genes work and boost the immune system. The goal was to see if this approach is safe and can help control the disease. 75 patients took part in this early-phase trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Klinikum Nürnberg

    Nuremberg, 90419, Germany

  • Ludwig-Maximilians-Universität München

    München, 81377, Germany

  • Uniklinik Köln

    Cologne, 50937, Germany

  • Universitätsklinikum Essen

    Essen, 45147, Germany

  • Universitätsklinikum Frankfurt

    Frankfurt, 60590, Germany

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, 20251, Germany

  • Universitätsklinikum Ulm

    Ulm, 89081, Germany

  • Universitätsklinikum Würzburg

    Würzburg, 97080, Germany

  • Universitätsmedizin Göttingen

    Göttingen, 37075, Germany

Conditions

Explore the condition pages connected to this study.